| The Tenex investment focus is primarily early stage ventures, whether they are product or company concepts, which can achieve a meaningful business benchmark with a capital infusion of between $250,000 and $750,000 from Tenex. These would include medical devices, healthcare information systems and services, clinical diagnostics, research products, medical equipment, hospital products and biotechnology. The Tenex investment may constitute all or part of a financing round. An average of two carefully screened companies seeking funding will present at bi-monthly Tenex sit down dinners. Between 100 and 125 potential investors attend the dinners. The expectation is that each member will have the inclination and capacity to invest at least $75,000 per year in deals of his choosing. Beyond that we look for our members to network and share their experiences with companies and members as the opportunities and situations present. information system companies. |
